Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Rochester, Minnesota


Purpose:

To evaluate the effectiveness of PriMatrix in the treatment of DFUs in subjects without significantly compromised arterial circulation.


Criteria:

Inclusion Criteria: - Type I or Type II diabetes with investigator-confirmed reasonable metabolic control - Peripheral neuropathy - A full thickness diabetic plantar foot ulcer of at least 1 cm2 but not exceeding 10 cm2 in area - An ulcer which has been in existence for a minimum of 30 days, prior to the day of screening Exclusion Criteria: - Suspected or confirmed signs/symptoms of wound infection - Wounds with exposed bone or tendon - Hypersensitivity to bovine collagen


NCT ID:

NCT01228526


Primary Contact:

Principal Investigator
Steven Kavros, DPM
Mayo Clinic


Backup Contact:

N/A


Location Contact:

Rochester, Minnesota
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.